AnuhyaKommalapatiMD

Physician

Dr. Kommalapati is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Prisma Health/University of South Carolina SOM Columbia (Columbia)Residency, Internal Medicine, 2017 - 2019
Guntur Medical College NTRClass of 2013

PubMed

Time to first treatment is an independent prognostic factor for Multiple Myeloma (MM).
Haris Hatic, Shealeigh Inselman, Jonathan Inselman, Anuhya Kommalapati, Sri Harsha Tella
Leukemia Research. 2022-12-01
Trials, Tribunals, and Opportunities for Lung Cancer KRASG12C Brain Metastases.
Anuhya Kommalapati, Aaron S Mansfield
Clinical Cancer Research. 2022-08-02
4 citations
Economic Cost and Sustainability of Oral Therapies in Precision Oncology.
Aakash P Desai, Caleb J Scheckel, Leah C Soderberg, Chelsee J Jensen, Jacob J Orme
JCO Oncology Practice. 2022-08-01

Journal Articles

Predictors of Survival in Adrenocortical Carcinoma: An Analysis from the National Cancer Database (NCDB)
Electron Kebebew, Anuhya Kommalapati, The Journal of Clinical Endocrinology and Metabolism

Lectures

Outcomes following lobectomy and pneumonectomy in stage IIIA non-small cell lung cancer (NSCLC) after neoadjuvant chemoradiation.
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
Time to surgery (TTS) in renal cell carcinoma (RCC): Predictors and association with overall survival (OS).
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019